529 related articles for article (PubMed ID: 31167919)
21. A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles.
Chen J; Zhang C; Zhou Y; Zhang X; Shen C; Ye X; Jiang W; Huang Z; Cong Y
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093091
[TBL] [Abstract][Full Text] [Related]
22. [Detection of enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Shanghai, 2002].
Yang ZH; Zhu QR; Li XZ; Wang XH; Wang JS; Hu JY; Tang W; Cui AL
Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):648-52. PubMed ID: 16191294
[TBL] [Abstract][Full Text] [Related]
23. Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity.
Ren J; Wang X; Zhu L; Hu Z; Gao Q; Yang P; Li X; Wang J; Shen X; Fry EE; Rao Z; Stuart DI
J Virol; 2015 Oct; 89(20):10500-11. PubMed ID: 26269176
[TBL] [Abstract][Full Text] [Related]
24. VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment.
Chen FH; Liu X; Fang HL; Nan N; Li Z; Ning NZ; Luo DY; Li T; Wang H
Front Immunol; 2019; 10():2564. PubMed ID: 31787970
[TBL] [Abstract][Full Text] [Related]
25. Enhanced human enterovirus 71 infection by endocytosis inhibitors reveals multiple entry pathways by enterovirus causing hand-foot-and-mouth diseases.
Yuan M; Yan J; Xun J; Chen C; Zhang Y; Wang M; Chu W; Song Z; Hu Y; Zhang S; Zhang X
Virol J; 2018 Jan; 15(1):1. PubMed ID: 29298696
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
[TBL] [Abstract][Full Text] [Related]
27. Amino Acid Variation at VP1-145 of Enterovirus 71 Determines Attachment Receptor Usage and Neurovirulence in Human Scavenger Receptor B2 Transgenic Mice.
Kobayashi K; Sudaka Y; Takashino A; Imura A; Fujii K; Koike S
J Virol; 2018 Aug; 92(15):. PubMed ID: 29848584
[TBL] [Abstract][Full Text] [Related]
28. Immunological evaluation and comparison of different EV71 vaccine candidates.
Chou AH; Liu CC; Chang JY; Lien SP; Guo MS; Tasi HP; Hsiao KN; Liu SJ; Sia C; Wu SC; Lee MS; Hsiao CH; Wang JR; Chow YH; Chong P
Clin Dev Immunol; 2012; 2012():831282. PubMed ID: 23008736
[TBL] [Abstract][Full Text] [Related]
29. The Pyrimidine Analog FNC Potently Inhibits the Replication of Multiple Enteroviruses.
Xu N; Yang J; Zheng B; Zhang Y; Cao Y; Huan C; Wang S; Chang J; Zhang W
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075935
[TBL] [Abstract][Full Text] [Related]
30. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement.
Huang SW; Wang YF; Yu CK; Su IJ; Wang JR
Virology; 2012 Jan; 422(1):132-43. PubMed ID: 22078110
[TBL] [Abstract][Full Text] [Related]
31. VP1 Amino Acid Residue 145 of Enterovirus 71 Is a Key Residue for Its Receptor Attachment and Resistance to Neutralizing Antibody during Cynomolgus Monkey Infection.
Fujii K; Sudaka Y; Takashino A; Kobayashi K; Kataoka C; Suzuki T; Iwata-Yoshikawa N; Kotani O; Ami Y; Shimizu H; Nagata N; Mizuta K; Matsuzaki Y; Koike S
J Virol; 2018 Aug; 92(15):. PubMed ID: 29848582
[TBL] [Abstract][Full Text] [Related]
32. Antiviral Efficacy of Flavonoids against Enterovirus 71 Infection in Vitro and in Newborn Mice.
Dai W; Bi J; Li F; Wang S; Huang X; Meng X; Sun B; Wang D; Kong W; Jiang C; Su W
Viruses; 2019 Jul; 11(7):. PubMed ID: 31284698
[TBL] [Abstract][Full Text] [Related]
33. Sulfonated azo dyes enhance the genome release of enterovirus A71 VP1-98K variants by preventing the virions from being trapped by sulfated glycosaminoglycans at acidic pH.
Meng T; Wong SM; Chua KB
Virology; 2021 Mar; 555():19-34. PubMed ID: 33422703
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of enterovirus 71 by adenosine analog NITD008.
Deng CL; Yeo H; Ye HQ; Liu SQ; Shang BD; Gong P; Alonso S; Shi PY; Zhang B
J Virol; 2014 Oct; 88(20):11915-23. PubMed ID: 25100827
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1.
Tan CW; Chan YF; Sim KM; Tan EL; Poh CL
PLoS One; 2012; 7(5):e34589. PubMed ID: 22563456
[TBL] [Abstract][Full Text] [Related]
36. Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening.
Xu L; Su W; Jin J; Chen J; Li X; Zhang X; Sun M; Sun S; Fan P; An D; Zhang H; Zhang X; Kong W; Ma T; Jiang C
Viruses; 2014 Jul; 6(7):2778-95. PubMed ID: 25036464
[TBL] [Abstract][Full Text] [Related]
37. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
[TBL] [Abstract][Full Text] [Related]
38. Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C.
Fang Y; Wang C; Wang C; Yang R; Bai P; Zhang XY; Kong J; Yin L; Qiu Y; Zhou X
J Virol; 2021 May; 95(12):. PubMed ID: 33789997
[TBL] [Abstract][Full Text] [Related]
39. Rheum emodin inhibits enterovirus 71 viral replication and affects the host cell cycle environment.
Zhong T; Zhang LY; Wang ZY; Wang Y; Song FM; Zhang YH; Yu JH
Acta Pharmacol Sin; 2017 Mar; 38(3):392-401. PubMed ID: 27840410
[TBL] [Abstract][Full Text] [Related]
40. Virucidal activity and the antiviral mechanism of acidic polysaccharides against Enterovirus 71 infection in vitro.
Li Z; Cui B; Liu X; Wang L; Xian Q; Lu Z; Liu S; Cao Y; Zhao Y
Microbiol Immunol; 2020 Mar; 64(3):189-201. PubMed ID: 31785100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
